Joshua L Katz
Overview
Explore the profile of Joshua L Katz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katz J, Geng Y, Billingham L, Sadagopan N, DeLay S, Subbiah J, et al.
Sci Rep
. 2024 Sep;
14(1):21959.
PMID: 39304717
Glioblastoma is a Grade 4 primary brain tumor defined by therapy resistance, diffuse infiltration, and near-uniform lethality. The underlying mechanisms are unknown, and no treatment has been curative. Using a...
2.
Wang S, Castro B, Katz J, Arrieta V, Najem H, Vazquez-Cervantes G, et al.
J Clin Invest
. 2024 Aug;
134(20).
PMID: 39207859
Glioblastoma (GBM) is a highly aggressive and malignant brain tumor with limited therapeutic options and a poor prognosis. Despite current treatments, the invasive nature of GBM often leads to recurrence....
3.
Chia T, Billingham L, Boland L, Katz J, Arrieta V, Shireman J, et al.
Front Immunol
. 2024 Feb;
14:1331287.
PMID: 38299146
Introduction: Glioblastoma multiforme (GBM) pathobiology is characterized by its significant induction of immunosuppression within the tumor microenvironment, predominantly mediated by immunosuppressive tumor-associated myeloid cells (TAMCs). Myeloid cells play a pivotal...
4.
Hou D, Wan H, Katz J, Wang S, Castro B, Vazquez-Cervantes G, et al.
Front Immunol
. 2024 Jan;
14:1295218.
PMID: 38268923
Understanding the spatial relationship and functional interaction of immune cells in glioblastoma (GBM) is critical for developing new therapeutics that overcome the highly immunosuppressive tumor microenvironment. Our study showed that...
5.
Rashidi A, Billingham L, Zolp A, Chia T, Silvers C, Katz J, et al.
Cell Metab
. 2023 Dec;
36(1):62-77.e8.
PMID: 38134929
Glioblastoma (GBM) is a malignancy dominated by the infiltration of tumor-associated myeloid cells (TAMCs). Examination of TAMC metabolic phenotypes in mouse models and patients with GBM identified the de novo...
6.
Hou D, Katz J, Lee-Chang C
STAR Protoc
. 2023 Apr;
4(2):102219.
PMID: 37083319
A B-cell-based cellular vaccine (B), produced from 4-1BBL B cells, can select tumor-specific B cells that, upon ex vivo culture, can generate tumor-specific antibodies and activate T cells. Here, we...